Comprehensive molecular profiles of low-grade serous ovarian carcinoma

被引:0
|
作者
ElNaggar, A. C. [1 ]
Robins, D. B. [1 ]
Arguello, D. [2 ]
Ulm, M. A. [1 ]
Mantia-Smaldone, G. M. [3 ]
Chu, C. [3 ]
Winer, I. [4 ]
Holloway, R. W. [5 ]
Krivak, T. C. [6 ]
Jones, N. L. [7 ]
Galvan-Turner, V. [8 ]
Herzog, T. J. [9 ]
Brown, J. [10 ]
机构
[1] Univ Tennessee, West Canc Ctr, Memphis, TN USA
[2] Caris Life Sci, Irving, TX USA
[3] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[4] Wayne State Univ, Detroit, MI USA
[5] Florida Hosp Canc Inst, Orlando, FL USA
[6] Western Penn Hosp, Pittsburgh, PA 15224 USA
[7] Univ S Alabama, Mitchell Canc Inst, Mobile, AL USA
[8] WVU Healthcare, Morgantown, WV USA
[9] UC Hlth Barrett Canc Ctr, Cincinnati, OH USA
[10] Carolinas Med Ctr, Levine Canc Inst, Charlotte, NC 28203 USA
关键词
D O I
10.1016/j.ygyno.2019.04.144
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1213
引用
收藏
页码:60 / 61
页数:3
相关论文
共 50 条
  • [41] Low-grade serous ovarian cancer: A review
    Kaldawy, Anis
    Segev, Yakir
    Lavie, Ofer
    Auslender, Ron
    Sopik, Victoria
    Narod, Steven A.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (02) : 433 - 438
  • [42] Epidemiology of low-grade serous ovarian cancer
    Plaxe, Steven C.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (04) : 459.e1 - 459.e9
  • [43] Low-grade serous ovarian cancer in pregnancy
    Peters, Inge
    Testa, Antonia Carla
    Arciuolo, Damiano
    Amant, Frederic
    Fagotti, Anna
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (06) : 804 - 808
  • [44] Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
    Ribeiro, Renan Ribeiro e
    Valenzuela, Ashley
    Beffa, Lindsey
    Sung, C. James
    Quddus, M. Ruhul
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 36
  • [45] Ovarian Low-grade and High-grade Serous Carcinoma Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems
    Vang, Russell
    Shih, Ie-Ming
    Kurman, Robert J.
    ADVANCES IN ANATOMIC PATHOLOGY, 2009, 16 (05) : 267 - 282
  • [46] THE ROLE OF CHEMOTHERAPY IN LOW-GRADE SEROUS OVARIAN CARCINOMA: REPORT OF TWO CASES
    Moreira-Barros, J.
    Vaz, I.
    Gunthert, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1982 - 1982
  • [47] Racial and ethnic disparities among patients with low-grade serous ovarian carcinoma
    Siemon, J.
    George, S.
    Huang, M.
    Slomovitz, B. M.
    Pearson, J. M.
    Schlumbrecht, M. P.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 122 - 122
  • [48] Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
    Singer, G
    Oldt, R
    Cohen, Y
    Wang, BG
    Sidransky, D
    Kurman, RJ
    Shih, IM
    MODERN PATHOLOGY, 2003, 16 (01) : 211A - 211A
  • [49] Ovarian Low-grade Serous Carcinoma Likely Deriving from the Fallopian Tube
    Chen, Hao
    Wang, Yiying
    Mu, Jingyi
    Lea, Jayanthi
    Zheng, Wenxin
    MODERN PATHOLOGY, 2018, 31 : 412 - 412
  • [50] Characterizing FOLR1 expression in low-grade serous ovarian carcinoma
    Rushton, Tullia
    Krause, Harris Benjamin
    Elliott, Andrew
    Karnezis, Anthony
    Toboni, Michael Driscoll
    Thaker, Premal H.
    Braxton, David R.
    Oberley, Matthew James
    Gershenson, David Marc
    Armstrong, Deborah Kay
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)